Craig Fraser - 16 Mar 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)

Role
President and CEO, Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol
WINT
Transactions as of
16 Mar 2022
Net transactions value
+$1,960
Form type
4
Filing time
17 Mar 2022, 17:33:40 UTC
Previous filing
15 Mar 2022
Next filing
30 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WINT Common Stock Purchase $1,960 +2,000 +0.96% $0.9799 210,058 16 Mar 2022 Direct
holding WINT Common Stock 147 16 Mar 2022 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.